Double screening of suramin derivatives on human colon cancer cells and on neural cells provides new therapeutic agents with reduced toxicity
- 1 December 1991
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 60 (3) , 213-219
- https://doi.org/10.1016/0304-3835(91)90116-y
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A suramin derivative induces enterocyte-like differentiation of human colon cancer cells without lysosomal storage disorderAnti-Cancer Drugs, 1990
- The concentration of glucose in the culture medium determines the effect of suramin on the growth and differentiation of the human colonic adenocarcinoma cell clone HT29-D4Cancer Letters, 1990
- Suramin Blockade of Insulinlike Growth Factor I-Stimulated Proliferation of Human Osteosarcoma CellsJNCI Journal of the National Cancer Institute, 1990
- Suramin-induced differentiation of the human colic adenocarcinoma cell clone HT29-D4 in serum-free mediumExperimental Cell Research, 1990
- Suramin inhibits proliferation of rat glioma cells and alters N-cam cell surface expressionInternational Journal of Cancer, 1990
- Inhibition of Human Immunodeficiency Virus Type I Reverse Transcriptase by Suramin-related CompoundsJournal of General Virology, 1987
- Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cellsJournal of Cellular Physiology, 1987
- Morphological and enzymatic heterogeneity of suramin-induced lysosomal storage disease in some tissues of mice and ratsExperimental and Molecular Pathology, 1986
- Suramin binds to platelet‐derived growth factor and inhibits its biological activityJournal of Cellular Biochemistry, 1985
- Induction of lysosomal storage by suraminNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1978